Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)

CUSIP: 68235C206

Q2 2025 13F Holders as of 30 Jun 2025

Holder snapshot 6 signals
Share change
+147,840
SEC-reported price per share
$3.02
Indexed holders
29
Value change
+$442,513
Number of buys
15
Number of sells
10
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
32,330,312

Security key

68235C206

Report period

Q2 2025

Indexed institutions

29

Top holders

10

Ownership snapshot

Top reported holders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Patrick W. Smith
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
3/15
Latest evidence
31 Mar 2025
3/4/5 13D/G 13F Lead comparable stake: 10% 12 rows are not safely comparable across share classes. 13D/G row: Patrick W. Smith Showing 1-6 of 15 holder rows.

Quick read

Patrick W. Smith leads the comparable SEC ownership view at 10%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Patrick W. Smith's linked filing trail.
Comparable ownership Top 3
Patrick W. Smith 10%
AWM Investment Company, Inc. 10%
BIO-RAD LABORATORIES, INC. 9.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Patrick W. Smith
3/4/5 13D/G
10%+ Owner
10%
Reported 13D/G · 26 Dec 2024
$6,679,894
3,258,485 shares
— 07 Feb 2025
AWM Investment Company, Inc.
13D/G 13F
Company
10%
Reported 13D/G · 31 Mar 2025
$9,685,464
2,857,069 shares
+$5,257,076 31 Mar 2025
BIO-RAD LABORATORIES, INC.
13D/G
9.7%
Reported 13D/G · 10 Feb 2025
$608,097
2,764,078 shares
$0 10 Feb 2025
PURA VIDA INVESTMENTS, LLC
3/4/5 13F
10%+ Owner · Company
—
mixed-class rows
$3,044,309
16,591,052 shares
mixed-class rows
— 14 Apr 2023
BROADWOOD CAPITAL INC
13F
Company
13F
—
denominator unverified
$34,914,906
11,410,100 shares
— 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$812,298
265,457 shares
— 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
29
Shares
15,248,594
Indexed holders
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 indexed holders
29
Q2 2025 indexed holders
29
Indexed holder difference
0
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .